N6-Benzoyl-7'-OH-N-trityl Morpholino adenosine manufacturers
|
| | N6-Benzoyl-7'-OH-N-trityl Morpholino adenosine Basic information |
| Product Name: | N6-Benzoyl-7'-OH-N-trityl Morpholino adenosine | | Synonyms: | N6-Benzoyl-7'-OH-N-trityl Morpholino adenosine;N-(9-[(2R,6S)-6-(Hydroxymethyl)-4-tritylmorpholine-2-yl]-purine-6-yl)benzamide;N6-Benzoyl-7'-hydroxy-N-trityl morpholino adenine;N6-Benzoyl-7'-hydroxymorpholino adenosine monomer;(2′R,6′S)-N6-benzoyl-9-[6′-(hydroxymethyl)-N-tritylmorpholin-2′-yl]adenine;N-(9-(6-(hydroxymethyl)-4-tritylmorpholin-2-yl)-9H-purin-6-yl) benzamide;PMO Adesnosine Precusor;Benzamide, N-[9-[(2R,6S)-6-(hydroxymethyl)-4-(triphenylmethyl)-2-morpholinyl]-9H-purin-6-yl]- | | CAS: | 956139-16-5 | | MF: | C36H32N6O3 | | MW: | 596.68 | | EINECS: | | | Product Categories: | | | Mol File: | 956139-16-5.mol |  |
| | N6-Benzoyl-7'-OH-N-trityl Morpholino adenosine Chemical Properties |
| Melting point | 172-174 °C | | density | 1.302±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 7.846±0.43(predicted) | | InChIKey | XFQQPEYYQOKYTE-IOWSJCHKSA-N | | SMILES | C(NC1=C2C(=NC=N1)N([C@@H]1O[C@H](CO)CN(C(C3=CC=CC=C3)(C3=CC=CC=C3)C3=CC=CC=C3)C1)C=N2)(=O)C1=CC=CC=C1 |
| | N6-Benzoyl-7'-OH-N-trityl Morpholino adenosine Usage And Synthesis |
| Uses | N6-Benzoyl-7’-OH-N-trityl morpholino adenine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | N6-Benzoyl-7'-OH-N-trityl Morpholino adenosine Preparation Products And Raw materials |
|